Literature DB >> 12587074

Multiple sclerosis-associated virus-related pol sequences found both in multiple sclerosis and healthy donors are more frequently expressed in multiple sclerosis patients.

Jerzy Nowak1, Danuta Januszkiewicz, Monika Pernak, Izabela Liweń, Mariola Zawada, Jolanta Rembowska, Karina Nowicka, Krzysztof Lewandowski, Hanna Hertmanowska, Mieczyslaw Wender.   

Abstract

In the etiopathogenesis of multiple sclerosis (MS), both genetic and environmental factors play an important role. Among environmental factors, viral infections are most likely connected with the etiology of MS. There are many evidence suggesting possible involvement of retroviruses in the development of autoimmune diseases including MS. Multiple sclerosis-associated retrovirus (MSRV) seems to be the important candidate for viral etiology of MS. The aim of the study was to analyze MSRV pol sequences in patients with MS. As control, groups of myasthenia gravis, Parkinson's disease, and migraine patients, and healthy individuals have been studied. The MSRV pol sequences have been analyzed in RNA isolated from the serum and in DNA and RNA of peripheral blood lymphocytes from untreated MS patients and control groups. The MSRV pol sequences have been detected by reverse transcriptase-polymerase chain reaction (RT-PCR) and PCR technique, using specific oligonucleotide primers. In the serum RNA (cDNA), MSRV pol sequences have been identified in 31/32 MS patients. MSRV pol sequences were detected in serum cDNA of 9/17 myasthenia gravis patients, 7/16 Parkinson's disease patients, 10/21 migraine patients, and 13/27 healthy individuals. MSRV pol sequences were observed also in RNA from lymphocytes of all MS patients, 12/17 myasthenia gravis patients, 9/16 Parkinson's disease patients, 14/21 migraine patients, and 18/27 healthy donors. In the DNA from peripheral blood lymphocytes of all studied patients and healthy individuals, MSRV pol sequences have been found. The observed pattern of fiber-fluorescence in situ hybridization (FISH) signals suggests the presence of multiple copies of MSRV pol sequences, most likely tandemly dispersed in the genome. It can be concluded that MSRV pol sequences are endogenous, widespread in lymphocytes DNA, and transcribed into RNA of MS patients as well as of other studied patients and healthy individuals. However, more frequent expression of MSRV sequences detected in lymphocytes RNA (cDNA), as well as their presence in higher frequency in the serum of MS patients, may suggest the involvement of MSRV in the etiopathogenesis on MS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12587074     DOI: 10.1080/13550280390173355

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  28 in total

1.  Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group.

Authors:  A D Sadovnick; G C Ebers; D A Dyment; N J Risch
Journal:  Lancet       Date:  1996-06-22       Impact factor: 79.321

2.  Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis.

Authors:  J A Garson; P W Tuke; P Giraud; G Paranhos-Baccala; H Perron
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

Review 3.  Viruses and multiple sclerosis.

Authors:  A G Dalgleish
Journal:  Acta Neurol Scand Suppl       Date:  1997

Review 4.  Possible involvement of endogenous retroviruses in the development of autoimmune disorders, especially multiple sclerosis.

Authors:  H B Rasmussen; J Clausen
Journal:  Acta Neurol Scand Suppl       Date:  1997

5.  Development of a pan-retrovirus detection system for multiple sclerosis studies.

Authors:  P W Tuke; H Perron; F Bedin; F Beseme; J A Garson
Journal:  Acta Neurol Scand Suppl       Date:  1997

6.  Isolation and phylogeny of endogenous retrovirus sequences belonging to the HERV-W family in primates.

Authors:  Heui-Soo Kim; Osamu Takenaka; Timothy J Crow
Journal:  J Gen Virol       Date:  1999-10       Impact factor: 3.891

7.  High-resolution DNA Fiber-FISH for genomic DNA mapping and colour bar-coding of large genes.

Authors:  R J Florijn; L A Bonden; H Vrolijk; J Wiegant; J W Vaandrager; F Baas; J T den Dunnen; H J Tanke; G J van Ommen; A K Raap
Journal:  Hum Mol Genet       Date:  1995-05       Impact factor: 6.150

Review 8.  Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system.

Authors:  L Steinman
Journal:  Cell       Date:  1996-05-03       Impact factor: 41.582

9.  Infrequency of detection of particle-associated MSRV/HERV-W RNA in the synovial fluid of patients with rheumatoid arthritis.

Authors:  P Gaudin; S Ijaz; P W Tuke; F Marcel; A Paraz; J M Seigneurin; B Mandrand; H Perron; J A Garson
Journal:  Rheumatology (Oxford)       Date:  2000-09       Impact factor: 7.580

10.  An endogenous retrovirus with nucleic acid sequences similar to those of the multiple sclerosis associated retrovirus at the human T-cell receptor alpha, delta gene locus.

Authors:  P M Alliel; J P Périn; R Pierig; F Rieger
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  1998-09       Impact factor: 1.770

View more
  23 in total

1.  Expression of HERV-Fc1, a human endogenous retrovirus, is increased in patients with active multiple sclerosis.

Authors:  Magdalena Janina Laska; Tomasz Brudek; Kari Konstantin Nissen; Tove Christensen; Anné Møller-Larsen; Thor Petersen; Bjørn Andersen Nexø
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 2.  MSRV/HERV-W/syncytin and its linkage to multiple sclerosis: the usability and the hazard of a human endogenous retrovirus.

Authors:  Antonina Dolei
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

Review 3.  Role of Exosomes in Human Retroviral Mediated Disorders.

Authors:  Monique Anderson; Fatah Kashanchi; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2018-04-14       Impact factor: 4.147

Review 4.  An alternative approach to medical genetics based on modern evolutionary biology. Part 3: HERVs in diseases.

Authors:  Frank P Ryan
Journal:  J R Soc Med       Date:  2009-10       Impact factor: 5.344

5.  Reduced expression of human endogenous retrovirus (HERV)-W GAG protein in the cingulate gyrus and hippocampus in schizophrenia, bipolar disorder, and depression.

Authors:  S Weis; I C Llenos; S Sabunciyan; J R Dulay; L Isler; R Yolken; H Perron
Journal:  J Neural Transm (Vienna)       Date:  2007-01-15       Impact factor: 3.575

6.  Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis.

Authors:  Giuseppe Mameli; Luciana Poddighe; Alessandra Mei; Elena Uleri; Stefano Sotgiu; Caterina Serra; Roberto Manetti; Antonina Dolei
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

7.  Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions.

Authors:  Hervé Perron; Françoise Lazarini; Klemens Ruprecht; Christine Péchoux-Longin; Danielle Seilhean; Véronique Sazdovitch; Alain Créange; Nicole Battail-Poirot; Geneviève Sibaï; Lyse Santoro; Michel Jolivet; Jean-Luc Darlix; Peter Rieckmann; Thomas Arzberger; Jean-Jacques Hauw; Hans Lassmann
Journal:  J Neurovirol       Date:  2005-02       Impact factor: 2.643

Review 8.  Retrotransposon-derived elements in the mammalian genome: a potential source of disease.

Authors:  R Druker; E Whitelaw
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

9.  Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis.

Authors:  Klemens Ruprecht; Felix Gronen; Marlies Sauter; Barbara Best; Peter Rieckmann; Nikolaus Mueller-Lantzsch
Journal:  J Neurovirol       Date:  2008-04       Impact factor: 2.643

Review 10.  The multiple sclerosis-associated retrovirus and its HERV-W endogenous family: a biological interface between virology, genetics, and immunology in human physiology and disease.

Authors:  Antonina Dolei; Hervé Perron
Journal:  J Neurovirol       Date:  2008-11-26       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.